Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is aimed to evaluate the efficacy, safety and tolerability of oxcarbazepine monotherapy in adults with partial seizures.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oxcarbazepine | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Epileptic activity at electroencephalography in rest | ||
| Flash light and hyperventilation test with electroencephalography | ||
| Frequency of epileptic episodes according to patient's diary | ||
| Electrocardiogram analysis for rhythm and conduction | ||
| Blood test for sodium, hepatic enzymes and blood cells |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life assessment at baseline, last visit | ||
| Tolerability and safety of 24 week's treatment with oxcarbazepine monotherapy in adult patients with partial seizures | ||
Not provided
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Novartis Pharmaceuticals | Novartis Pharmaceuticals | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Epilepsy Department of the Moscow Research Institute of Psychiatry | Moscow | Russia | ||||
| Neurology and Neurosurgery Department of the Moscow State Medico-stomatology University |
Not provided
| ID | Term |
|---|---|
| D004827 | Epilepsy |
| D012640 | Seizures |
| D004828 | Epilepsies, Partial |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
Not provided
Not provided
| ID | Term |
|---|---|
| D000078330 | Oxcarbazepine |
| ID | Term |
|---|---|
| D002220 | Carbamazepine |
| D003984 | Dibenzazepines |
| D006575 | Heterocyclic Compounds, 3-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Rate of patients with total and partial control of epilepsy |
| Rate of patients requiring additional antiepileptic drugs |
| Moscow |
| Russia |
| Neurology and Neurosurgery Department of the Russian State Medical University | Moscow | Russia |
| Neurology Department of I.M. Sechenov Moscow Medical Academy | Moscow | Russia |
| Neurology Department of Pediatric faculty of the Russian State Medical University | Moscow | Russia |
| Neurology Department of the Moscow region Research Institute named after M.F. Vladimirskiy | Moscow | Russia |
| Epilepsy Department of the V.M. Bekhterev Sant-Petersburg Psychoneurology Institute | Saint Petersburg | Russia |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006571 | Heterocyclic Compounds |